157 related articles for article (PubMed ID: 20623695)
1. Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro.
Kraitzer A; Kloog Y; Haklai R; Zilberman M
J Pharm Sci; 2011 Jan; 100(1):133-49. PubMed ID: 20623695
[TBL] [Abstract][Full Text] [Related]
2. Novel farnesylthiosalicylate (FTS)-eluting composite structures.
Kraitzer A; Kloog Y; Zilberman M
Eur J Pharm Sci; 2009 Jun; 37(3-4):351-62. PubMed ID: 19491026
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of antiproliferative drug release from bioresorbable porous structures.
Kraitzer A; Alperstein D; Kloog Y; Zilberman M
J Biomed Mater Res A; 2013 May; 101(5):1302-10. PubMed ID: 23065767
[TBL] [Abstract][Full Text] [Related]
4. Long-term in vitro study of paclitaxel-eluting bioresorbable core/shell fiber structures.
Kraitzer A; Ofek L; Schreiber R; Zilberman M
J Control Release; 2008 Mar; 126(2):139-48. PubMed ID: 18201789
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-loaded composite fibers: microstructure and emulsion stability.
Kraitzer A; Zilberman M
J Biomed Mater Res A; 2007 May; 81(2):427-36. PubMed ID: 17117472
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-eluting composite fibers: drug release and tensile mechanical properties.
Zilberman M; Kraitzer A
J Biomed Mater Res A; 2008 Feb; 84(2):313-23. PubMed ID: 17607755
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
8. Novel bioresorbabale composite fiber structures loaded with proteins for tissue regeneration applications: microstructure and protein release.
Levy Y; Zilberman M
J Biomed Mater Res A; 2006 Dec; 79(4):779-87. PubMed ID: 16883584
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
10. A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
Sun J; Chen Y; Li K; Huang Y; Fu X; Zhang X; Zhao W; Wei Y; Xu L; Zhang P; Venkataramanan R; Li S
Acta Biomater; 2016 Oct; 43():282-291. PubMed ID: 27422196
[TBL] [Abstract][Full Text] [Related]
11. PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Zhang X; Lu J; Huang Y; Zhao W; Chen Y; Li J; Gao X; Venkataramanan R; Sun M; Stolz DB; Zhang L; Li S
Bioconjug Chem; 2013 Mar; 24(3):464-72. PubMed ID: 23425093
[TBL] [Abstract][Full Text] [Related]
12. Thermally sensitive micelles self-assembled from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) for controlled delivery of paclitaxel.
Liu SQ; Tong YW; Yang YY
Mol Biosyst; 2005 Jul; 1(2):158-65. PubMed ID: 16880979
[TBL] [Abstract][Full Text] [Related]
13. Farnesylthiosalicylic acid: inhibition of proliferation and enhancement of apoptosis of hormone-dependent breast cancer cells.
Santen RJ; Lynch AR; Neal LR; McPherson RA; Yue W
Anticancer Drugs; 2006 Jan; 17(1):33-40. PubMed ID: 16317288
[TBL] [Abstract][Full Text] [Related]
14. Controlled release of analgesic drugs from porous bioresorbable structures for various biomedical applications.
Shemesh M; Gilboa E; Ben-Gal TS; Zilberman M
J Biomater Sci Polym Ed; 2014; 25(4):410-30. PubMed ID: 24313726
[TBL] [Abstract][Full Text] [Related]
15. Delivery of doxorubicin and paclitaxel from double-layered microparticles: The effects of layer thickness and dual-drug vs. single-drug loading.
Lee WL; Guo WM; Ho VHB; Saha A; Chong HC; Tan NS; Tan EY; Loo SCJ
Acta Biomater; 2015 Nov; 27():53-65. PubMed ID: 26340886
[TBL] [Abstract][Full Text] [Related]
16. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
Liu SQ; Tong YW; Yang YY
Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings.
Westedt U; Wittmar M; Hellwig M; Hanefeld P; Greiner A; Schaper AK; Kissel T
J Control Release; 2006 Mar; 111(1-2):235-46. PubMed ID: 16466824
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-eluting bioresorbable composite fibers for wound healing applications: microstructure, drug delivery and mechanical properties.
Elsner JJ; Zilberman M
Acta Biomater; 2009 Oct; 5(8):2872-83. PubMed ID: 19416766
[TBL] [Abstract][Full Text] [Related]
20. Gentamicin-eluting bioresorbable composite fibers for wound healing applications.
Zilberman M; Golerkansky E; Elsner JJ; Berdicevsky I
J Biomed Mater Res A; 2009 Jun; 89(3):654-66. PubMed ID: 18442118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
